The BalancedInvestor Club

DXR Market Analysis

Overview

Fundamentals

P/E ratio6.37Forward 64.52
EPS (TTM)$1.64329.3% YoY
Profit margin34359.0%HEALTHCARE
Market cap$60.8MMicro cap

Wall Street coverage

$22.50median target· current $9.80 (+129.6%)2 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
64.52
PEG ratio
0.00
P/B
1.33
P/S (TTM)
2279.53
EV/EBITDA
—

Profitability & growth

ROE (TTM)
22.5%
Operating margin
-9661.0%
Revenue growth YoY
-82.6%
Dividend yield
—
Beta
0.14
Last earnings
Aug 29, 2025 · Estimate $0.00 · Reported $-0.07
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Daxor Corporation

Daxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. The company is headquartered in New York, New York.

Classification

Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
109 MECO LANE, OAK RIDGE, TN
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$60.8M
Shares outstanding$5.8M
52W high$14.76
52W low$7.10

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer